CERRI, SILVIA

Nome completo

CERRI, SILVIA

Afferenza

DIPARTIMENTO DI BIOLOGIA ANIMALE (attivo dal 01/01/1900 al 31/12/2011)

Mostra records

Risultati 1 - 20 di 44 (tempo di esecuzione: 0.02 secondi).

A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease

2014-01-01 Ambrosi, G.; Cerri, S.; Blandini, F.

Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer

2017-01-01 Gandolfi, Daniela; Cerri, Silvia; Mapelli, Jonathan; Polimeni, Mariarosa; Tritto, Simona; Fuzzati Armentero, Marie Therese; Bigiani, Albertino; Blandini, Fabio; Mapelli, Lisa; D'Angelo, EGIDIO UGO

Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease

2018-01-01 Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G.

Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease

2018-01-01 Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G.

Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease

2011-01-01 Armentero, M. -T.; Levandis, G.; Bazzini, E.; Cerri, S.; Ghezzi, C.; Blandini, F.

Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration

2016-01-01 Pellegrini, C.; Fornai, M.; Colucci, R.; Tirotta, E.; Blandini, F.; Levandis, G.; Cerri, S.; Segnani, C.; Ippolito, C.; Bernardini, N.; Cseri, K.; Blandizzi, C.; Hasko, G.; Antonioli, L.

An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease

2020-01-01 Cerri, S.; Blandini, F.

Cell proliferation and death in the brain of active and hibernating frogs

2009-01-01 Cerri, Silvia; Bottiroli, G.; Bottone, MARIA GRAZIA; Barni, Sergio; Bernocchi, Graziella

Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat

2017-01-01 Ambrosi, G.; Kustrimovic, N.; Siani, F.; Rasini, E.; Cerri, S.; Ghezzi, C.; Dicorato, G.; Caputo, S.; Marino, F.; Cosentino, M.; Blandini, F.

Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity

2019-01-01 Mus, L.; Siani, F.; Giuliano, C.; Ghezzi, C.; Cerri, S.; Blandini, F.

Developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum

2011-01-01 Cerri, Silvia; Piccolini, VALERIA MARIA; Santin, Giada; Bottone, MARIA GRAZIA; De Pascali, S. A.; Migoni, D.; Iadarola, Paolo; Fanizzi, F. P.; Bernocchi, Graziella

Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease

2015-01-01 Fuzzati-Armentero, M. -T.; Cerri, S.; Levandis, G.; Ambrosi, G.; Montepeloso, E.; Antoninetti, G.; Blandini, F.; Baqi, Y.; Muller, C. E.; Volpini, R.; Costa, G.; Simola, N.; Pinna, A.

Effects of cisplatin on neuronal cell B50: involvement of mitochondria in apoptosis induction.

2006-01-01 Avella, Debora; Soldani, Cristiana; Bottone, MARIA GRAZIA; Veneroni, Paola; Pisu Maria, Bonaria; Cerri, Silvia; Bernocchi, Graziella

Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration

2017-01-01 Pellegrini, C.; Antonioli, L.; Colucci, R.; Tirotta, E.; Gentile, D.; Ippolito, C.; Segnani, C.; Levandis, G.; Cerri, S.; Blandini, F.; Barocelli, E.; Ballabeni, V.; Bernardini, N.; Blandizzi, C.; Fornai, M.

Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease

2021-01-01 Cerri, S.; Ghezzi, C.; Ongari, G.; Croce, S.; Avenali, M.; Zangaglia, R.; Di Monte, D. A.; Valente, E. M.; Blandini, F.

Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease

2020-01-01 Milanese, C.; Gabriels, S.; Barnhoorn, S.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Wallace, D. F.; Blandini, F.; Di Monte, D. A.; Subramaniam, V. N.; Mastroberardino, P. G.

Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease

2020-01-01 Avenali, M.; Blandini, F.; Cerri, S.

Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine

2019-01-01 Blandini, F.; Cilia, R.; Cerri, S.; Pezzoli, G.; Schapira, A. H. V.; Mullin, S.; Lanciego, J. L.

Immediate early genes regulation in rat cerebellar cortex during long-term synaptic plasticity induction.

2011-01-01 Polimeni, Mariarosa; Gandolfi, Daniela; Cerri, Silvia; Mapelli, Jonathan; Tritto, Simona; Alloni, Maurizio; Armentero, M. T.; Blandini, Fabio; D'Angelo, EGIDIO UGO

In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease

2018-01-01 Rizzi, N.; Brunialti, E.; Cerri, S.; Cermisoni, G.; Levandis, G.; Cesari, N.; Maggi, A.; Blandini, F.; Ciana, P.

Titolo	Data di pubblicazione	Autore(i)
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease	1-gen-2014	Ambrosi, G.; Cerri, S.; Blandini, F.
Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer	1-gen-2017	Gandolfi, Daniela; Cerri, Silvia; Mapelli, Jonathan; Polimeni, Mariarosa; Tritto, Simona; Fuzzati Armentero, Marie Therese; Bigiani, Albertino; Blandini, Fabio; Mapelli, Lisa; D'Angelo, EGIDIO UGO
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease	1-gen-2018	Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G.
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease	1-gen-2018	Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G.
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease	1-gen-2011	Armentero, M. -T.; Levandis, G.; Bazzini, E.; Cerri, S.; Ghezzi, C.; Blandini, F.
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration	1-gen-2016	Pellegrini, C.; Fornai, M.; Colucci, R.; Tirotta, E.; Blandini, F.; Levandis, G.; Cerri, S.; Segnani, C.; Ippolito, C.; Bernardini, N.; Cseri, K.; Blandizzi, C.; Hasko, G.; Antonioli, L.
An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease	1-gen-2020	Cerri, S.; Blandini, F.
Cell proliferation and death in the brain of active and hibernating frogs	1-gen-2009	Cerri, Silvia; Bottiroli, G.; Bottone, MARIA GRAZIA; Barni, Sergio; Bernocchi, Graziella
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat	1-gen-2017	Ambrosi, G.; Kustrimovic, N.; Siani, F.; Rasini, E.; Cerri, S.; Ghezzi, C.; Dicorato, G.; Caputo, S.; Marino, F.; Cosentino, M.; Blandini, F.
Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity	1-gen-2019	Mus, L.; Siani, F.; Giuliano, C.; Ghezzi, C.; Cerri, S.; Blandini, F.
Developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum	1-gen-2011	Cerri, Silvia; Piccolini, VALERIA MARIA; Santin, Giada; Bottone, MARIA GRAZIA; De Pascali, S. A.; Migoni, D.; Iadarola, Paolo; Fanizzi, F. P.; Bernocchi, Graziella
Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease	1-gen-2015	Fuzzati-Armentero, M. -T.; Cerri, S.; Levandis, G.; Ambrosi, G.; Montepeloso, E.; Antoninetti, G.; Blandini, F.; Baqi, Y.; Muller, C. E.; Volpini, R.; Costa, G.; Simola, N.; Pinna, A.
Effects of cisplatin on neuronal cell B50: involvement of mitochondria in apoptosis induction.	1-gen-2006	Avella, Debora; Soldani, Cristiana; Bottone, MARIA GRAZIA; Veneroni, Paola; Pisu Maria, Bonaria; Cerri, Silvia; Bernocchi, Graziella
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration	1-gen-2017	Pellegrini, C.; Antonioli, L.; Colucci, R.; Tirotta, E.; Gentile, D.; Ippolito, C.; Segnani, C.; Levandis, G.; Cerri, S.; Blandini, F.; Barocelli, E.; Ballabeni, V.; Bernardini, N.; Blandizzi, C.; Fornai, M.
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease	1-gen-2021	Cerri, S.; Ghezzi, C.; Ongari, G.; Croce, S.; Avenali, M.; Zangaglia, R.; Di Monte, D. A.; Valente, E. M.; Blandini, F.
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease	1-gen-2020	Milanese, C.; Gabriels, S.; Barnhoorn, S.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Wallace, D. F.; Blandini, F.; Di Monte, D. A.; Subramaniam, V. N.; Mastroberardino, P. G.
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease	1-gen-2020	Avenali, M.; Blandini, F.; Cerri, S.
Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine	1-gen-2019	Blandini, F.; Cilia, R.; Cerri, S.; Pezzoli, G.; Schapira, A. H. V.; Mullin, S.; Lanciego, J. L.
Immediate early genes regulation in rat cerebellar cortex during long-term synaptic plasticity induction.	1-gen-2011	Polimeni, Mariarosa; Gandolfi, Daniela; Cerri, Silvia; Mapelli, Jonathan; Tritto, Simona; Alloni, Maurizio; Armentero, M. T.; Blandini, Fabio; D'Angelo, EGIDIO UGO
In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease	1-gen-2018	Rizzi, N.; Brunialti, E.; Cerri, S.; Cermisoni, G.; Levandis, G.; Cesari, N.; Maggi, A.; Blandini, F.; Ciana, P.